The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Transmedics Group Inc shares valued at $540,324 were purchased by EDWARD BASILE on Oct 29 ’25. At $130.45 per share, EDWARD BASILE acquired 4,142 shares.
Also, Hassanein Waleed H purchased 8,400 shares, netting a total of over 996,912 in proceeds. Following the buying of shares at $118.68 each, the insider now holds 477,759 shares.
Before that, Hassanein Waleed H had added 8,475 shares to its account. In a trade valued at $985,209, the President & CEO bought Transmedics Group Inc shares for $116.25 each. Upon closing the transaction, the insider’s holdings increased to 8,475 shares, worth approximately $65.31 million.
As published in a research note from Needham on October 23, 2025, Transmedics Group Inc [TMDX] has been rated up from a Hold to a Buy and the price target has been revised to $148. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in mid October. As of September 16, 2025, Evercore ISI has initiated its “an Outperform” rating for TMDX. Earlier on September 04, 2025, Stifel initiated its rating. Their recommendation was “a Hold” for TMDX stock.
Analyzing TMDX Stock Performance
On last trading session, Transmedics Group Inc [NASDAQ: TMDX] rose 3.55% to $134.32. The stock’s lowest price that day was $128.1962, but it reached a high of $137.67 in the same session. During the last five days, there has been a surge of approximately 12.36%. Over the course of the year, Transmedics Group Inc shares have jumped approximately 7.31%. Shares of the company reached a 52-week high of $145.50 on 06/16/25 and a 52-week low of $55.00 on 01/21/25.
Support And Resistance Levels for Transmedics Group Inc (TMDX)
According to the 24-hour chart, there is a support level at 129.12, which, if violated, would cause prices to drop to 123.92. In the upper region, resistance lies at 138.59. The next price resistance is at 142.87. RSI (Relative Strength Index) is 69.41 on the 14-day chart, showing neutral technical sentiment.
Is Transmedics Group Inc subject to short interest?
Stocks of Transmedics Group Inc saw a sharp steep in short interest on 2025-10-15 dropping by -0.42 million shares to 7.97 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 8.39 million shares. A decline of -5.31% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 9.12 of the overall float, the days-to-cover ratio (short ratio) decline to 9.12.
Which companies own the most shares of Transmedics Group Inc (TMDX)?
In terms of Transmedics Group Inc share price expectations, FactSet research, analysts set an average price target of 148 in the next 12 months, up nearly 14.1% from the previous closing price of $129.71. Analysts anticipate Transmedics Group Inc stock to reach 155 by 2025, with the lowest price target being 145. In spite of this, 7 analysts ranked Transmedics Group Inc stock as Buy at the end of 2025. On December 17, 2024, JP Morgan assigned a price target of “a Neutral” to the stock and downgraded coverage with a $75.
